OFFICIAL Jon 'Bones' Jones Limited Edition Tee

OFFICIAL Jon 'Bones' Jones Limited Edition Tee
You save

"I designed this EXCLUSIVE limited edition tee just for my fans!" --Jon
Proceeds support the Pediatric Cancer Foundation dedicated to funding research to eliminate childhood cancer.
[Hoodie available in style drop-down]

Worldwide Shipping Available

{{styles[0].only_selection_name}}
{{product.variant.name}}
Please select your size first
Campaign has finished

"I designed this EXCLUSIVE limited edition tee just for my fans!" --Jon
Proceeds support the Pediatric Cancer Foundation dedicated to funding research to eliminate childhood cancer.
[Hoodie available in style drop-down]

Worldwide Shipping Available

2,923 items sold

Also available as

'The Number 1 Pound for Pound Fighter' and his supporters

Show your support for Jon 'Bones' Jones as he gets set to take on Ovince St Preux on April 23!

Worldwide shipping is available.

ABOUT THE CAUSE

The Pediatric Cancer Foundation is a nonprofit organization dedicated to funding research to eliminate childhood cancer. Our focus is to fund research to find less toxic, more targeted therapies by partnering with leading hospitals nationwide.

The Pediatric Cancer Foundation (PCF) relies on five primary sources of funding for its financial support: individual contributions, corporate contributions, planned giving, grants, and fundraising events.

Current Sunshine Project Initiatives:

Clinical Research: Conducting two Phase 1 clinical trials at 15 hospitals nationwide.
Pediatric Total Cancer Care Program: Blood and tissue banking program to further personalized medicine for children.
Translational Research: PCF laboratory at Moffitt Cancer Center is rapidly evaluating agents for Phase I trials. Preclinical Studies: Funded 8 pre-clinical grants totaling $600,000 to Sunshine Project investigators

Proud to Announce:

87% of total expenses are directly allocated to program services.
4-star rated charity by Charity Navigator and a Gold Level by GuideStar for sound fiscal management as well as accreditation by the BBB Wise Giving Alliance; all of which are the highest ratings a nonprofit can receive.
Donated more than 1.2 million dollars to The Sunshine Project during the 2014-2015 fiscal year.

History: Pediatric Cancer Foundation
In 1991, Melissa Helms and Risa Tramel faced every parent’s worst nightmare when their infant daughters were diagnosed with cancer. The two women met at St. Joseph’s Children’s Hospital in Tampa while their infant daughters were undergoing cancer treatments. Through advancements of research and technology, Helms and Tramel's daughters survived and are now healthy young adults. Through this experience, Melissa and Risa were inspired to continue fighting this disease and together founded the Pediatric Cancer Foundation, a non-profit organization whose mission is to fund research that will lead to the elimination of childhood cancer worldwide.

Over the past 23 years, the Pediatric Cancer Foundation has donated more than $6 million to researchers. For the first 15 years, the Pediatric Cancer Foundation funded seed grants at St. Joseph’s Children’s Hospital and Moffitt Cancer Center in Tampa; All Children’s Research Institute in St. Petersburg, The University of Florida in Gainesville, and The University of Miami School of Medicine.

In 2005, the Pediatric Cancer Foundation formed The Sunshine Project, an innovative collaboration with one goal: to bring together the nation’s top doctors and researchers to fast-track new treatments and increase the survival rate for children battling cancer.

Through the establishment of The Sunshine Project, the Pediatric Cancer Foundation has developed a business model that capitalizes on the strengths of researchers from all fields of science and streamlines the process helping to accelerate the development of new treatments.

Best of all, the Pediatric Cancer Foundation has proven that this collaborative model works. Since 2005, we have funded four Phase 1 Clinical Trials. New compounds have been, and continue to be, tested and hold great promise for children who have not experienced positive results under the standard treatment protocol.